Rhenman & Partners Asset Management AB as of March 31, 2024
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 84 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cigna Corp (CI) | 4.7 | $50M | 137k | 363.19 | |
| Eli Lilly & Co. (LLY) | 4.0 | $42M | 54k | 777.96 | |
| Tenet Healthcare Corp Com New (THC) | 3.8 | $40M | 380k | 105.11 | |
| Boston Scientific Corporation (BSX) | 3.8 | $40M | 582k | 68.49 | |
| Anthem (ELV) | 3.4 | $36M | 70k | 518.54 | |
| Abbvie (ABBV) | 3.3 | $35M | 190k | 182.10 | |
| Hca Holdings (HCA) | 3.2 | $33M | 100k | 333.53 | |
| Regeneron Pharmaceuticals (REGN) | 3.1 | $33M | 34k | 962.49 | |
| Cooper Cos (COO) | 2.9 | $31M | 301k | 101.46 | |
| Merck & Co (MRK) | 2.7 | $29M | 219k | 131.95 | |
| Becton, Dickinson and (BDX) | 2.7 | $29M | 116k | 247.45 | |
| Medtronic SHS (MDT) | 2.7 | $28M | 325k | 87.15 | |
| Oscar Health Cl A (OSCR) | 2.4 | $25M | 1.7M | 14.87 | |
| Procept Biorobotics Corp (PRCT) | 2.3 | $24M | 487k | 49.42 | |
| McKesson Corporation (MCK) | 2.2 | $24M | 44k | 536.85 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.2 | $24M | 57k | 418.01 | |
| Natera (NTRA) | 2.1 | $22M | 240k | 91.46 | |
| Abbott Laboratories (ABT) | 2.0 | $21M | 185k | 113.66 | |
| Shockwave Med | 2.0 | $21M | 64k | 325.63 | |
| BioMarin Pharmaceutical (BMRN) | 2.0 | $21M | 238k | 87.34 | |
| Intuitive Surgical Com New (ISRG) | 1.9 | $20M | 51k | 399.09 | |
| UnitedHealth (UNH) | 1.9 | $20M | 41k | 494.70 | |
| Dex (DXCM) | 1.8 | $19M | 139k | 138.70 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 1.7 | $18M | 147k | 120.42 | |
| Royalty Pharma Shs Class A (RPRX) | 1.6 | $17M | 545k | 30.37 | |
| Align Technology (ALGN) | 1.6 | $16M | 50k | 327.92 | |
| Dynavax Technologies Corp Com New (DVAX) | 1.4 | $14M | 1.2M | 12.41 | |
| Iovance Biotherapeutics (IOVA) | 1.3 | $14M | 955k | 14.82 | |
| Cytokinetics Com New (CYTK) | 1.3 | $14M | 198k | 70.11 | |
| Biogen Idec (BIIB) | 1.2 | $12M | 57k | 215.63 | |
| Viking Therapeutics (VKTX) | 1.1 | $12M | 145k | 82.00 | |
| Axsome Therapeutics (AXSM) | 1.1 | $12M | 144k | 79.80 | |
| Apellis Pharmaceuticals (APLS) | 1.0 | $11M | 178k | 58.78 | |
| AmerisourceBergen (COR) | 1.0 | $10M | 43k | 242.99 | |
| Penumbra (PEN) | 1.0 | $10M | 46k | 223.18 | |
| Centene Corporation (CNC) | 1.0 | $10M | 129k | 78.48 | |
| Alignment Healthcare (ALHC) | 1.0 | $10M | 2.0M | 4.96 | |
| EXACT Sciences Corporation (EXAS) | 0.9 | $9.9M | 143k | 69.06 | |
| Madrigal Pharmaceuticals (MDGL) | 0.9 | $9.7M | 37k | 267.04 | |
| Intra Cellular Therapies (ITCI) | 0.9 | $9.5M | 138k | 69.20 | |
| Gilead Sciences (GILD) | 0.9 | $9.3M | 127k | 73.25 | |
| Inspire Med Sys (INSP) | 0.9 | $9.0M | 42k | 214.79 | |
| Zimmer Holdings (ZBH) | 0.8 | $8.9M | 68k | 131.98 | |
| Neurocrine Biosciences (NBIX) | 0.8 | $8.1M | 59k | 137.92 | |
| Iqvia Holdings (IQV) | 0.7 | $7.8M | 31k | 252.89 | |
| Novocure Ord Shs (NVCR) | 0.7 | $7.7M | 495k | 15.63 | |
| Essa Pharma Com New (EPIX) | 0.7 | $7.7M | 912k | 8.49 | |
| Thermo Fisher Scientific (TMO) | 0.7 | $7.6M | 13k | 581.21 | |
| Arvinas Ord (ARVN) | 0.7 | $7.0M | 170k | 41.28 | |
| Nuvalent Inc-a (NUVL) | 0.6 | $6.6M | 88k | 75.09 | |
| Alnylam Pharmaceuticals (ALNY) | 0.6 | $6.3M | 42k | 149.45 | |
| Insulet Corporation (PODD) | 0.6 | $6.0M | 35k | 171.40 | |
| Immunocore Hldgs Ads (IMCR) | 0.5 | $5.2M | 80k | 65.00 | |
| Xencor (XNCR) | 0.5 | $4.8M | 219k | 22.13 | |
| Avantor (AVTR) | 0.4 | $4.4M | 171k | 25.57 | |
| Syndax Pharmaceuticals (SNDX) | 0.4 | $4.2M | 179k | 23.80 | |
| Immunovant (IMVT) | 0.4 | $4.1M | 126k | 32.31 | |
| Janux Therapeutics (JANX) | 0.4 | $3.9M | 105k | 37.65 | |
| Kura Oncology (KURA) | 0.3 | $3.6M | 167k | 21.33 | |
| Revance Therapeutics | 0.3 | $3.5M | 702k | 4.92 | |
| Charles River Laboratories (CRL) | 0.3 | $3.4M | 13k | 270.95 | |
| Alpine Immune Sciences | 0.3 | $3.4M | 86k | 39.64 | |
| Krystal Biotech (KRYS) | 0.3 | $3.4M | 19k | 177.93 | |
| Augmedix (AUGX) | 0.3 | $3.3M | 800k | 4.09 | |
| Bridgebio Pharma (BBIO) | 0.3 | $3.2M | 105k | 30.92 | |
| Alkermes SHS (ALKS) | 0.3 | $3.0M | 110k | 27.07 | |
| Stryker Corporation (SYK) | 0.3 | $2.9M | 8.0k | 357.87 | |
| Danaher Corporation (DHR) | 0.3 | $2.7M | 11k | 249.72 | |
| Inari Medical Ord | 0.3 | $2.7M | 56k | 47.98 | |
| Glaukos (GKOS) | 0.2 | $2.5M | 27k | 94.29 | |
| Encompass Health Corp (EHC) | 0.2 | $2.4M | 29k | 82.58 | |
| Mirum Pharmaceuticals (MIRM) | 0.2 | $2.3M | 92k | 25.12 | |
| Privia Health Group (PRVA) | 0.2 | $2.2M | 114k | 19.59 | |
| Pliant Therapeutics (PLRX) | 0.2 | $2.2M | 145k | 14.90 | |
| Inmune Bio Ord (INMB) | 0.2 | $2.1M | 178k | 11.75 | |
| Relay Therapeutics (RLAY) | 0.2 | $1.9M | 230k | 8.30 | |
| Igm Biosciences (IGMS) | 0.2 | $1.9M | 195k | 9.65 | |
| Bruker Corporation (BRKR) | 0.2 | $1.9M | 20k | 93.94 | |
| Tg Therapeutics (TGTX) | 0.2 | $1.9M | 124k | 15.21 | |
| Intellia Therapeutics (NTLA) | 0.1 | $1.3M | 48k | 27.51 | |
| Amgen (AMGN) | 0.1 | $1.2M | 4.3k | 284.32 | |
| Bio-techne Corporation (TECH) | 0.1 | $1.1M | 16k | 70.39 | |
| Acadia Healthcare (ACHC) | 0.1 | $1.0M | 13k | 79.22 | |
| Repligen Corporation (RGEN) | 0.1 | $920k | 5.0k | 183.92 |
